BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2476272)

  • 21. The essential role of endogenous IFN alpha/beta in the anti-metastatic action of sensitized T lymphocytes in mice injected with Friend erythroleukemia cells.
    Gresser I; Maury C; Kaido T; Bandu MT; Tovey MG; Maunoury MT; Fantuzzi L; Gessani S; Greco G; Belardelli F
    Int J Cancer; 1995 Nov; 63(5):726-31. PubMed ID: 7591292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interferon treatment markedly inhibits the development of tumor metastases in the liver and spleen and increases survival time of mice after intravenous inoculation of Friend erythroleukemia cells.
    Gresser I; Maury C; Woodrow D; Moss J; Grütter MG; Vignaux F; Belardelli F; Maunoury MT
    Int J Cancer; 1988 Jan; 41(1):135-42. PubMed ID: 3422071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of mouse alpha/beta-interferon of the multiplication of alpha/beta-interferon-resistant Friend erythroleukemia cells cocultured with mouse hepatocytes.
    Yasui H; Proietti E; Vignaux F; Eid P; Gresser I
    Cancer Res; 1990 Jun; 50(12):3533-9. PubMed ID: 2140290
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Wheat germ agglutinin-binding protein changes in highly malignant Friend leukemia cells metastasizing to the liver.
    Elia G; Ferrantini M; Belardelli F; Proietti E; Gresser I; Amici C; Benedetto A
    Clin Exp Metastasis; 1988; 6(5):347-62. PubMed ID: 3163957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-tumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend leukemia cells. V. Comparisons with the action of tumor necrosis factor.
    Gresser I; Belardelli F; Tavernier J; Fiers W; Podo F; Federico M; Carpinelli G; Duvillard P; Prade M; Maury C
    Int J Cancer; 1986 Nov; 38(5):771-8. PubMed ID: 3464571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-tumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend leukemia cells. VI. Adjuvant therapy after surgery in the inhibition of liver and spleen metastases.
    Gresser I; Maury C; Belardelli F
    Int J Cancer; 1987 Jun; 39(6):789-92. PubMed ID: 2438237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-tumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend erythroleukemia cells. VIII. Role of the immune system in the inhibition of visceral metastases.
    Gresser I; Maury C; Carnaud C; De Maeyer E; Maunoury MT; Belardelli F
    Int J Cancer; 1990 Sep; 46(3):468-74. PubMed ID: 2394514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined interleukin 1/interleukin 2 therapy of mice injected with highly metastatic Friend leukemia cells: host antitumor mechanisms and marked effects on established metastases.
    Ciolli V; Gabriele L; Sestili P; Varano F; Proietti E; Gresser I; Testa U; Montesoro E; Bulgarini D; Mariani G
    J Exp Med; 1991 Feb; 173(2):313-22. PubMed ID: 1671080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcriptional induction of H2 (class I) antigens and beta 2 microglobulin by interferon-gamma in interferon-sensitive and interferon-resistant Friend leukemia cells.
    Coccia E; Marziali G; Fiorucci G; Romeo G; Affabris E; Battistini A; Rossi GB
    J Biol Regul Homeost Agents; 1992; 6(1):21-5. PubMed ID: 1442172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antitumor effect of thymosin alpha 1/interleukin-2 or thymosin alpha 1/interferon alpha,beta following cyclophosphamide in mice injected with highly metastatic Friend erythroleukemia cells.
    Garaci E; Pica F; Mastino A; Palamara AT; Belardelli F; Favalli C
    J Immunother Emphasis Tumor Immunol; 1993 Jan; 13(1):7-17. PubMed ID: 8435433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cure of mice with established metastatic friend leukemia cell tumors by a combined therapy with tumor cells expressing both interferon-alpha 1 and herpes simplex thymidine kinase followed by ganciclovir.
    Santodonato L; Ferrantini M; Gabriele L; Proietti E; Venditti M; Musiani P; Modesti A; Modica A; Lupton SD; Belardelli F
    Hum Gene Ther; 1996 Jan; 7(1):1-10. PubMed ID: 8825863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Susceptibility of Friend virus antigen-modulated erythroleukemic cells to lysis by T lymphocytes from mice with dormant Friend virus infections.
    Genovesi EV; Marx PA; Wheelock EF
    J Immunol; 1979 Mar; 122(3):795-800. PubMed ID: 312825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metastasis of mouse T lymphoma cells is controlled by the level of major histocompatibility complex class I H-2Dk antigens.
    VandenDriessche T; Geldhof A; Bakkus M; Toussaint-Demylle D; Brijs L; Thielemans K; Verschueren H; De Baetselier P
    Int J Cancer; 1994 Jul; 58(2):217-25. PubMed ID: 8026885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A radiosensitive T-lymphocyte associated with resistance of DBA/2 mice harboring Friend leukemia virus-dormant infections to transplantable Friend leukemia virus-erythroleukemia cells.
    DiCicco LM; Truitt GA; Wheelock EF
    Cancer Res; 1986 Jan; 46(1):127-32. PubMed ID: 3509990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth inhibition of Friend erythroleukaemia cell tumours in vivo by a synthetic analogue of prostaglandin A: an action independent of natural killer-activity.
    Marini S; Palamara AT; Garaci E; Santoro MG
    Br J Cancer; 1990 Mar; 61(3):394-9. PubMed ID: 2328205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antitumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend leukemia cells. I.
    Belardelli F; Gresser I; Maury C; Maunoury MT
    Int J Cancer; 1982 Dec; 30(6):813-20. PubMed ID: 6186614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-tumor effects of interleukin-2 and interleukin-1 in mice transplanted with different syngeneic tumors.
    Belardelli F; Ciolli V; Testa U; Montesoro E; Bulgarini D; Proietti E; Borghi P; Sestili P; Locardi C; Peschle C
    Int J Cancer; 1989 Dec; 44(6):1108-16. PubMed ID: 2606579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of in vitro interferon treatment on the rapid clearance of murine leukemia cells in vivo.
    Neri M; Zei T; Rossi GB; Coccia EM; Bonmassar E; Iorio AM
    J Biol Regul Homeost Agents; 1990; 4(2):60-6. PubMed ID: 1701956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lysis of FLD-3 Friend erythroleukemia cells in vitro and in vivo: effect of 89Sr treatment and Friend virus infection.
    Lust JA; Bennett M; Kumar V
    Int J Cancer; 1984 Jan; 33(1):107-13. PubMed ID: 6582049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spontaneous fusion in vivo between normal host and tumor cells: possible contribution to tumor progression and metastasis studied with a lectin-resistant mutant tumor.
    Kerbel RS; Lagarde AE; Dennis JW; Donaghue TP
    Mol Cell Biol; 1983 Apr; 3(4):523-38. PubMed ID: 6687920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.